Stock Ratings / Health Care / ADUS / options

WGS (58) PRVA (57) AVAH (65) TDOC (56) ⌘ Pro Terminal →

Addus HomeCare Corporation (ADUS) Options Positioning, Max Pain & Unusual Sweeps

$124.34 +1.77% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $124.50

Addus HomeCare Corporation (ADUS) carries a Roarable Rating of C+ (Hold) with 69/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

📊 Historical Track Record: Scores of 69/100 (C+) historically posted market-perform odds over rolling 90-day windows (+2.0% avg 90D alpha vs SPY) →

ROARABLE C+ • HOLD / WATCH Cap $2.32B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $124.50 (+0.13%)🧬 Cannibal Buyback (-2.08% YoY Shares)⚙️ Cash Engine: 12/20 (C-) • 7.3% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 69/100 (C+) historically posted market-perform odds over rolling 90-day windows (+2.0% avg 90D alpha vs SPY • 57.3% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERHOLD / WATCH • C+

2-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw C · Rk B+

Each axis scored 0–20

12M PRICE TARGET CONE+4.9% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ADUS)Realized 20D OHLCV Swing Band: ±5%

Deterministic 5-Pillar Attribution (69/100 Composite)

🔍 WHY ADUS SCORES 69/100 (C+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Macro Regime Fit+16/20 pts (23% of score)

FRED Regime × Technicals: 94% of 52W Range • RSI-14 at 73.1 (OVERBOUGHT (>70))

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+15/20 pts (22% of score)

Altman Z-Score 5.83 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 9/9

▼ #1 Drag / Risk Factor: Whale & Options Positioning11/20 pts (-9 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-9 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C$114.33+1.4% Next Q

Q2 (-2Q)

Grade C+$115.98+5% Next Q

Q3 (-1Q)

Grade B-$121.81+2.1% Next Q

Current

Grade C+$124.34+2% Hist 90D α

Trajectory: C (61) → C+ (69)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the ADUS Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 69/100 (C+) score, ADUS faces multiple-compression risk if 24.2x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Broader market pullbacks can still drag down strong stocks in the short run.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-2.08% YoY Shares) — any gross margin slip below 30.0% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($117.00) or 200D SMA ($106.35) invalidates the momentum regime and cuts Target Base ($130.49) toward Bear Floor ($101.78).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $ADUS• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “ADUS Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 69%NO 31%Trade / Inspect Odds →

CALL VS. PUT WHALE SHARE

— (No Active Options Snapshot)

Put/Call Ratio: — (No Active Options Snapshot)

MAX-PAIN EXPIRATION MAGNET

— (No Active Options Snapshot)

No active options chain max-pain snapshot on file

HISTORICAL 20D VOLATILITY SWING

±5%

Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (ADUS)

— (No Active Options Snapshot) — No unusual CBOE strike concentration anomalies recorded in the current database snapshot for ADUS.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

🏆 Enter Free $100K Paper Arena →

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Options & Swing Structure Desk

Whale Flow & Momentum Playbook: Evaluating ADUS & AI Leaders Without Chasing Tops

✓Institutional whale strikes & implied earnings move audit on ADUS
✓How disciplined traders manage risk using pre-published trigger & invalidation levels
✓Includes nightly RQD rating-change & forensic signal email alerts on tracked leaders

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

ADUS // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +28.33%▲ ASCENDING CHANNEL

2026-10-30O $125.7H $126.6L $124.3C $124.3VOL 300.3K

RES: $141.6SUP: $111.1SMA50: $117.0SMA200: $106.4

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ADUS Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 ADUS Butterfly Map → + Track ADUS →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

17.9%/yr Implied 5Y Growth

vs. +23.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on ADUS today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for ADUS. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for ADUS today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ADUS)

Health Care Rank #101 of 1016 ⚔️ WGS vs ADUS Full Matrix →

1. Head-to-Head Health Care Peer Comparison (ADUS vs. WGS, PRVA, AVAH, TDOC)

Industry: Medical/Nursing Services (29 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Addus HomeCare Corporation (ADUS) ranks #101 by composite RQD confidence (69/100, grade C+) and #234 by equity capitalization ($2.32B). Within this direct 5-issuer industry benchmark cohort, ADUS leads on earnings valuation at 24.2x trailing P/E, while AVAH leads on capital efficiency and profitability with 15.7% ROIC and 33.3% gross margin. ADUS currently leads its immediate peer cohort in composite quantitative strength at 69/100 (C+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
ADUS ACTIVE Addus HomeCare Corporation	C+	69/100	24.2x	32.5%	9.1%	+1.77%	$2.32B	Benchmark Subject
WGS GeneDx Holdings Corp. (Class A)	D+	58/100	—	69.7%	-4.1%	+9.79%	$2.12B	/wgs-vs-adus →
PRVA Privia Health Group Inc.	D+	57/100	122.6x	—	10.5%	+0.71%	$2.81B	/prva-vs-adus →
AVAH Aveanna Healthcare Holdings Inc.	C	65/100	—	33.3%	15.7%	+1.53%	$2.89B	/avah-vs-adus →
TDOC Teladoc Health Inc.	D+	56/100	—	—	-17.0%	+26.89%	$1.59B	/tdoc-vs-adus →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001468328

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Addus HomeCare Corporation (ADUS) reported GAAP revenue of $1.42B (+23.2% vs. FY2024 revenue of $1.15B , and +34.4% cumulative change since FY2023) , GAAP net income of $95.9M, operating cash flow of $111.5M, and free cash flow of $103.8M (-6.0% YoY). On the balance sheet, ADUS closed FY2025 with $1.44B in total assets against $121.0M in total debt (Altman Z-Score: 5.83, Piotroski F-Score: 9/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$1.42B	$95.9M	$111.5M	$103.8M	$1.44B	$121.0M
FY2024 (FY)	2024-12-31	$1.15B	$73.6M	$116.4M	$110.4M	$1.41B	$218.4M
FY2023 (FY)	2023-12-31	$1.06B	$62.5M	$112.2M	$112.2M	—	—

3. ADUS Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is ADUS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Addus HomeCare Corporation (NASDAQ: ADUS) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 69/100 at a spot price of $124.34 (+1.77% 1D, market cap $2.32B). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 15/20, FRED Macro Regime Fit 16/20, and SEC Balance-Sheet Forensics 15/20. Across 1016 tracked Health Care issuers, ADUS ranks #101 in composite RQD confidence.

How does ADUS compare to WGS and PRVA in the Health Care sector?

Within the Health Care sector (Medical/Nursing Services), ADUS carries a Roarable C+ (69/100 RQD), trailing P/E of 24.2x, gross margin of 32.5%, and ROIC of 9.1%. By comparison, WGS (GeneDx Holdings Corp. (Class A)) holds a D+ grade (58/100 RQD, P/E N/A, ROIC -4.1%, cap $2.12B) and PRVA (Privia Health Group Inc.) posts a D+ grade (57/100 RQD, P/E 122.6x, ROIC 10.5%, cap $2.81B). Among the 5-stock peer group, ADUS leads on earnings multiple (24.2x) while AVAH leads on capital efficiency (15.7% ROIC).

What are the biggest fundamental strengths and SEC risk factors for ADUS?

Per ADUS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001468328), Addus HomeCare Corporation generated $1.42B in revenue (+23.2% YoY), $95.9M in net income, and $103.8M in free cash flow against $1.44B in total assets and $121.0M in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is ADUS trading relative to its 50-day, 200-day, and 52-week technical levels?

ADUS last traded at $124.34 (+1.77% on volume of 331,621 shares), positioning the stock +6.27% above its 50-day simple moving average ($117.00) and +16.92% above its 200-day simple moving average ($106.35). Across its 52-week range of $87.95 to $126.62, ADUS sits at the 94.1% percentile with a 14-day RSI of 73.1 (OVERBOUGHT (>70)) and an implied next-earnings move of ±5.0% ($118.12 to $130.56).